GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Insider Ownership

ViaDerma (ViaDerma) Insider Ownership : 65.70 % (As of Jun. 22, 2024)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ViaDerma's insider ownership is 65.70%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ViaDerma's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ViaDerma's Float Percentage Of Total Shares Outstanding is 99.99%.


ViaDerma Insider Ownership Historical Data

The historical data trend for ViaDerma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Insider Ownership Chart

ViaDerma Historical Data

The historical data trend for ViaDerma can be seen below:

2009-08-31 2009-09-30 2009-10-31 2009-11-30 2009-12-31 2010-01-31 2010-02-28 2010-03-31 2010-04-30
Insider Ownership 37.41 37.41 37.41 16.42 16.42 16.42 16.42 65.70 65.70

ViaDerma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.

ViaDerma (ViaDerma) Headlines

From GuruFocus

ViaDerma, Inc. Files Amended Financial Statements

By Marketwired Marketwired 08-24-2021

ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development

By Stock market mentor Stock market mentor 01-12-2023

ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021

By Marketwired Marketwired 01-13-2021

ViaDerma, Inc. Nearing Initial Order from Large Hospital Network

By Marketwired Marketwired 05-13-2021

ViaDerma, Inc. Provides an Update on its Current Marketing Efforts

By Marketwired Marketwired 08-27-2020

ViaDerma, Inc. Provides Updates on Current Business Activities

By Marketwired Marketwired 06-24-2021

ViaDerma, Inc. Provides a Corporate Update

By GlobeNewswire GlobeNewswire 01-16-2020